Content about Diabetes mellitus

April 11, 2012

MinuteClinic has announced that this spring it is offering a free monitoring visit for patients with diabetes to help keep their health in check between visits to a primary care provider.

WOONSOCKET, R.I. — MinuteClinic has announced that this spring it is offering a free monitoring visit for patients with diabetes to help keep their health in check between visits to a primary care provider.

The complimentary monitoring service, which is available seven days a week, is administered by a MinuteClinic nurse practitioner or physician assistant and includes:

  • Hemoglobin A1C and blood-glucose test (as needed);

  • Blood pressure check;

  • Body mass index (BMI);

April 9, 2012

The Food and Drug Administration has approved a change to the label of a Novo Nordisk drug stating that it offers superior blood-sugar control to a competing drug made by Merck, based on results of two clinical studies, Novo Nordisk said Monday.

PRINCETON, N.J. — The Food and Drug Administration has approved a change to the label of a Novo Nordisk drug stating that it offers superior blood-sugar control to a competing drug made by Merck, based on results of two clinical studies, Novo Nordisk said Monday.

April 5, 2012

Lilly Diabetes has donated funds to the Diabetes Scholars Foundation, the drug maker announced Wednesday.

INDIANAPOLIS — Lilly Diabetes has donated funds to the Diabetes Scholars Foundation, the drug maker announced Wednesday.

Lilly Diabetes said the $100,000 contribution will be donated to the foundation's scholarship fund, which supports the organization's mission to empower young people with Type 1 diabetes. The donation will be used to fund college scholarships for students with Type 1 diabetes, as well as conference scholarships for families to attend the 2012 Children with Diabetes Friends for Life conference in Orlando, Fla.

April 4, 2012

CVS/pharmacy officially announced on Wednesday the April schedule of Project Health (Proyecto Salud in Spanish), a wellness program delivering more than $21 million worth of free health screenings to multicultural communities throughout 2012.

WOONSOCKET, R.I. — CVS/pharmacy officially announced on Wednesday the April schedule of Project Health (Proyecto Salud in Spanish), a wellness program delivering more than $21 million worth of free health screenings to multicultural communities throughout 2012.

As part of National Minority Health Month, CVS/pharmacy will offer free health screenings at select stores in African-American and Latino communities in Atlanta, Chicago, Dallas-Fort Worth, Detroit, Houston, Los Angeles, Miami, New York, Philadelphia and Washington, D.C.

April 3, 2012

Drug maker Amylin Pharmaceuticals has filed for regulatory approval of a drug to treat diabetes and elevated triglycerides in the bloodstream in children and adults with a rare disorder.

SAN DIEGO — Drug maker Amylin Pharmaceuticals has filed for regulatory approval of a drug to treat diabetes and elevated triglycerides in the bloodstream in children and adults with a rare disorder.

April 3, 2012

Marsh Supermarkets on Tuesday recognized National Public Health Week with the introduction of a program to help people with diabetes better understand, manage and live with the disease — more than 9% of Indiana residents have been diagnosed with diabetes, the grocer noted.

INDIANAPOLIS — Marsh Supermarkets on Tuesday recognized National Public Health Week with the introduction of a program to help people with diabetes better understand, manage and live with the disease — more than 9% of Indiana residents have been diagnosed with diabetes, the grocer noted.

April 3, 2012

Drug maker Merck has introduced a new program that's designed to provide resources and information to help patients with Type 2 diabetes commit to living a diabetes-friendly lifestyle.

WHITEHOUSE STATION, N.J. — Drug maker Merck has introduced a new program that's designed to provide resources and information to help patients with Type 2 diabetes commit to living a diabetes-friendly lifestyle.

April 2, 2012

A diabetes treatment made by Novo Nordisk is safe for pregnant women, according to a recent decision by the Food and Drug Administration.

NEW YORK — A diabetes treatment made by Novo Nordisk is safe for pregnant women, according to a recent decision by the Food and Drug Administration.

Novo Nordisk said Monday the FDA had approved Levemir (insulin detemir [rDNA origin]) for a pregnancy category B classification, meaning that when used by pregnant women, the insulin did not increase the risk of harm to fetuses. The agency's decision was based on results of a clinical trial involving 310 women that compared Levemir to another insulin product.

The insulin is used to treat Type 1 and Type 2 diabetes.

April 2, 2012

A medication commonly prescribed for patients with Type 2 diabetes also may play a critical role in patients at risk of developing certain cancers.

NEW YORK — A medication commonly prescribed for patients with Type 2 diabetes also may play a critical role in patients at risk of developing certain cancers.

In three separate studies published in Cancer Prevention Research, a journal of the American Association for Cancer Research, findings showed how metformin may protect against oral cancer and liver cancer, as well as slow the growth rate of prostate cancer among men prior to prostatectomy.

March 30, 2012

Daiichi Sankyo and NGM Biopharmaceuticals said they signed a research and licensing agreement to develop treatments for Type 1 and Type 2 diabetes. The drugs would work by reviving beta cells, the decline of which contributes to the disease.

SOUTH SAN FRANCISCO, Calif. — Daiichi Sankyo and NGM Biopharmaceuticals said they signed a research and licensing agreement to develop treatments for Type 1 and Type 2 diabetes. The drugs would work by reviving beta cells, the decline of which contributes to the disease.

March 29, 2012

In line with the 24th annual American Diabetes Association Alert Day, the American Diabetes Association debuted its new and improved diabetes risk test.

ALEXANDRIA, Va. — In line with the 24th annual American Diabetes Association Alert Day, the American Diabetes Association debuted its new and improved diabetes risk test.

March 29, 2012

A commonly prescribed diabetes drug also may have the capability of protecting the heart, according to a Swedish study.

NEW YORK — A commonly prescribed diabetes drug also may have the capability of protecting the heart, according to a Swedish study.

March 26, 2012

Lifestyle intervention and treatment with metformin provide safe, long-term, cost-effective means of preventing Type 2 diabetes and should be incorporated into prevention strategies for reducing the dramatic rise in incidence of Type 2 diabetes in the United States, according to two new analyses and an editorial published in the April issue of Diabetes Care.

ALEXANDRIA, Va. — Lifestyle intervention and treatment with metformin provide safe, long-term, cost-effective means of preventing Type 2 diabetes and should be incorporated into prevention strategies for reducing the dramatic rise in incidence of Type 2 diabetes in the United States, according to two new analyses and an editorial published in the April issue of Diabetes Care.

March 23, 2012

Supervalu banner Shop 'n Save Pharmacy has joined the UnitedHealth Group's Diabetes Prevention and Control Alliance.

MINNETONKA, Minn. — Supervalu banner Shop 'n Save Pharmacy has joined the UnitedHealth Group's Diabetes Prevention and Control Alliance.

March 22, 2012

Changes to the House of Representatives' budget for the upcoming fiscal year could put an American Diabetes Association movement at risk, the ADA said.

ALEXANDRIA, Va. — Changes to the House of Representatives' budget for the upcoming fiscal year could put an American Diabetes Association movement at risk, the ADA said.

March 22, 2012

People with diabetes are at increased risk of hearing loss, which has prompted two groups to encourage those living with the disease to have their hearing checked.

WASHINGTON — People with diabetes are at increased risk of hearing loss, which has prompted two groups to encourage those living with the disease to have their hearing checked.

The American Diabetes Association and the Better Hearing Institute are launching the effort as part of the ADA's Diabetes Alert Day, on Tuesday, which also includes an effort to encourage people to check if they are at risk of developing Type 2 diabetes.

March 21, 2012

An investigational Type 2 diabetes drug may improve glycemic control among patients that are unable to improve their blood sugar with high doses of insulin alone, according to a new study.

NEW YORK — An investigational Type 2 diabetes drug may improve glycemic control among patients that are unable to improve their blood sugar with high doses of insulin alone, according to a new study.

March 19, 2012

American Idol sensation Crystal Bowersox will deliver an acoustic performance at the second Walk with Walgreens Family Fun Day and Health Fair, to be held March 24, the Diabetes Research Institute Foundation announced Friday.

HOLLYWOOD, Fla. — "American Idol" sensation Crystal Bowersox will deliver an acoustic performance at the second Walk with Walgreens Family Fun Day and Health Fair, to be held March 24, the Diabetes Research Institute Foundation announced Friday.

March 16, 2012

A new study has indicated that the consumption of white rice can increase one's risk of developing Type 2 diabetes.

BOSTON — A new study has indicated that the consumption of white rice can increase one's risk of developing Type 2 diabetes.

March 15, 2012

Reducing the cutoff of hemoglobin A1C to determine if a patient has prediabetes could be cost effective, according to a new study.

NEW YORK — Reducing the cutoff of hemoglobin A1C to determine if a patient has prediabetes could be cost effective, according to a new study.

March 14, 2012

Women that are seated for longer periods of time are more likely to develop diabetes when compared with men, according to a new study.

NEW YORK — Women that are seated for longer periods of time are more likely to develop diabetes when compared with men, according to a new study.

March 13, 2012

Pfizer and Indian drug maker Biocon have ended a partnership that the companies started in 2010 to develop biosimilar treatments for diabetes, the companies said.

NEW YORK — Pfizer and Indian drug maker Biocon have ended a partnership that the companies started in 2010 to develop biosimilar treatments for diabetes, the companies said.

March 9, 2012

A new partnership aims to educate pharmacists, other healthcare professionals, caregivers and patients about diabetes and about how pharmacists can work with physicians to help patients manage the condition.

WASHINGTON — A new partnership aims to educate pharmacists, other healthcare professionals, caregivers and patients about diabetes and about how pharmacists can work with physicians to help patients manage the condition.

The American Pharmacists Association, the APhA Foundation and the American Diabetes Association announced the collaboration Friday, saying it would develop new resources and also promote existing programs, such as the ADA's Stop Diabetes Movement and the APhA's Pharmaceutical Care for Patients with Diabetes certification program.

March 8, 2012

The market for drugs to treat diabetes — especially Type 2 diabetes — has shown quite a bit of activity lately.

The market for drugs to treat diabetes — especially Type 2 diabetes — has shown quite a bit of activity lately. At the end of January, the Food and Drug Administration approved Bydureon (exenatide), a once-weekly version of the drug Byetta, which was originally developed by Alkermes and subsequently developed further under an alliance between Amylin Pharmaceuticals and Eli Lilly that the two companies formed in 2002. In November 2011, however, Amylin and Lilly terminated their alliance in the wake of an announced diabetes drug partnership between Lilly and Boehringer Ingelheim.

March 8, 2012

The number of patients with diabetes is not decreasing any time soon, and one of the most important fronts in the battle lies at the pharmacy counter.


The number of patients with diabetes is not decreasing any time soon, and one of the most important fronts in the battle lies at the pharmacy counter.